Maximize Returns on Royalty Pharma plc (RPRX) Investments Using Our Online Dividend Calculator.
$31,805.00
Total Share Cost
$0.10
Hourly
$2.41
Daily
$73.36
Monthly
$220.09
Quarterly
RPRX Payout Frequency
$440.18
Semi-Annual
$880.36
Yearly
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.